Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus

被引:11
作者
Watanabe, Shun [1 ]
Ishihara, Hiroki [1 ]
Takagi, Toshio [1 ]
Kondo, Tsunenori [2 ]
Ishiyama, Ryo [1 ]
Fukuda, Hironori [1 ]
Yoshida, Kazuhiko [1 ]
Iizuka, Junpei [1 ]
Kobayashi, Hirohito [2 ]
Ishida, Hideki [1 ]
Tanabe, Kazunari [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan
[2] Tokyo Womens Med Univ Med Ctr East, Dept Urol, Tokyo, Japan
关键词
kidney cancer; cachexia; systemic inflammation; renal cancer; prognosis; SKELETAL-MUSCLE; PROGNOSTIC-SIGNIFICANCE; RADICAL NEPHRECTOMY; SURGICAL-TREATMENT; SOLID TUMORS; CANCER; COMPLICATIONS; INVOLVEMENT; SURGERY; INTERLEUKIN-6;
D O I
10.1093/jjco/hyaa275
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Sarcopenia is associated with oncological outcomes in various types of cancer. However, the impact of sarcopenia in renal cell carcinoma with inferior vena cava thrombus remains unclear. We herein evaluated the prognostic significance of sarcopenia for renal cell carcinoma with inferior vena cava thrombus following nephrectomy and thrombectomy. Methods: Patients who underwent nephrectomy and thrombectomy for renal cell carcinoma with inferior vena cava thrombus at our department between 2004 and 2019 were retrospectively evaluated. Their sarcopenic status, determined by sex, body mass index and skeletal muscle index, was calculated using pre-surgical radiographic imaging. We compared the post-operative cancer-specific survival and overall survival, surgical data and duration of post-operative hospitalization of sarcopenic and non-sarcopenic patients. Results: Out of 83 patients, 54 (65%) were sarcopenic. Sarcopenic patients had significantly shorter cancer-specific survival (median: 33.3 months vs. not reached, P = 0.0323) and overall survival (32.0 months vs. not reached, P = 0.0173) than non-sarcopenic patients. Furthermore, multivariate analyses showed that sarcopenia was an independent factor for cancer-specific survival (hazard ratio: 2.76, P = 0.0212) and overall survival (hazard ratio: 2.93, P = 0.014). The incidence rate of surgical complications (any grade: 35.2% vs. 27.6%, P = 0.482; grades >= 3: 7.4% vs. 10.3%, P = 0.648) or duration of post-operative hospitalization (median: 11 vs. 10 days, P = 0.148) was not significantly different between sarcopenic and non-sarcopenic patients. Conclusions: In conclusion, this study showed that sarcopenia was an independent prognostic factor for renal cell carcinoma with inferior vena cava thrombus after nephrectomy and tumor thrombectomy. Thus, sarcopenia evaluation can be utilized as an effective prognosticator of postoperative survival.
引用
收藏
页码:819 / 825
页数:7
相关论文
共 45 条
[1]   Perioperative Outcomes Following Surgical Resection of Renal Cell Carcinoma with Inferior Vena Cava Thrombus Extending Above the Hepatic Veins: A Contemporary Multicenter Experience [J].
Abel, E. Jason ;
Thompson, R. Houston ;
Margulis, Vitaly ;
Heckman, Jennifer E. ;
Merril, Megan M. ;
Darwish, Oussama M. ;
Krabbe, Laura-Maria ;
Boorjian, Stephen A. ;
Leibovich, Bradley C. ;
Wood, Christopher G. .
EUROPEAN UROLOGY, 2014, 66 (03) :584-592
[2]   Prediction of Everolimus Toxicity and Prognostic Value of Skeletal Muscle Index in Patients With Metastatic Renal Cell Carcinoma [J].
Auclin, Edouard ;
Bourillon, Camille ;
De Maio, Eleonora ;
By, Marie Agnes ;
Seddik, Sofiane ;
Fournier, Laure ;
Auvray, Marie ;
Dautruche, Antoine ;
Vano, Yann-Alexandre ;
Thibault, Constance ;
Joly, Florence ;
Brunereau, Laurent ;
Gomez-Roca, Carlos ;
Chevreau, Christine ;
Elaidi, Reza ;
Oudard, Stephane .
CLINICAL GENITOURINARY CANCER, 2017, 15 (03) :350-355
[3]   Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy [J].
Baracos, V. E. ;
Arribas, L. .
ANNALS OF ONCOLOGY, 2018, 29 :1-9
[4]   The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus [J].
Blute, ML ;
Leibovich, BC ;
Lohse, CM ;
Cheville, JC ;
Zincke, H .
BJU INTERNATIONAL, 2004, 94 (01) :33-41
[5]   Sarcopenia: revised European consensus on definition and diagnosis [J].
Cruz-Jentoft, Alfonso J. ;
Bahat, Gulistan ;
Bauer, Juergen ;
Boirie, Yves ;
Bruyere, Olivier ;
Cederholm, Tommy ;
Cooper, Cyrus ;
Landi, Francesco ;
Rolland, Yves ;
Sayer, Avan Aihie ;
Schneider, Stephane M. ;
Sieber, Cornel C. ;
Topinkova, Eva ;
Vandewoude, Maurits ;
Visser, Marjolein ;
Zamboni, Mauro .
AGE AND AGEING, 2019, 48 (01) :16-31
[6]   Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].
Dindo, D ;
Demartines, N ;
Clavien, PA .
ANNALS OF SURGERY, 2004, 240 (02) :205-213
[7]   Subcutaneous adiposity is an independent predictor of mortality in cancer patients [J].
Ebadi, Maryam ;
Martin, Lisa ;
Ghosh, Sunita ;
Field, Catherine J. ;
Lehner, Richard ;
Baracos, Vickie E. ;
Mazurak, Vera C. .
BRITISH JOURNAL OF CANCER, 2017, 117 (01) :148-155
[8]  
Fukushima Hiroshi, 2017, Clin Genitourin Cancer, V15, pe229, DOI 10.1016/j.clgc.2016.08.004
[9]   Prognostic Significance of Sarcopenia in Patients with Metastatic Renal Cell Carcinoma [J].
Fukushima, Hiroshi ;
Nakanishi, Yasukazu ;
Kataoka, Madoka ;
Tobisu, Ken-ichi ;
Koga, Fumitaka .
JOURNAL OF UROLOGY, 2016, 195 (01) :26-32
[10]   Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients [J].
Gu, Weijie ;
Wu, Junlong ;
Liu, Xiaohang ;
Zhang, Hailiang ;
Shi, Guohai ;
Zhu, Yao ;
Ye, Dingwei .
SCIENTIFIC REPORTS, 2017, 7